FDA Inspection 904022 — R-Pharm Germany GmbH

R-Pharm Germany GmbH — FEI 3002807165

The FDA completed an inspection of R-Pharm Germany GmbH on Nov 7, 2014 in Illertissen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 7, 2014
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Illertissen (Germany)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.